Real-World Data Analysis of Patients Affected by Immune-Mediated Thrombotic Thrombocytopenic Purpura in Italy

Real-World Data Analysis of Patients Affected by Immune-Mediated Thrombotic Thrombocytopenic Purpura in Italy

<b>Background:</b> The therapeutic management of immune-mediated thrombotic thrombocytopenic purpura (iTTP) has recently benefited from the introduction of caplacizumab, an agent directed at the inhibition of platelet aggregation. This real-world analysis investigated the epidemiology an...

Full description

Bibliographic Details
Main Authors: Emanuele Angelucci, Andrea Artoni, Luana Fianchi, Melania Dovizio, Biagio Iacolare, Stefania Saragoni, Luca Degli Esposti
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Clinical Medicine
Subjects:
immune-mediated thrombotic thrombocytopenic purpura
caplacizumab
epidemiology
mortality
real-world evidence
Online Access:https://www.mdpi.com/2077-0383/13/5/1342

Internet

https://www.mdpi.com/2077-0383/13/5/1342

Similar Items